Business profile & competitive position
Church & Dwight Co., Inc. (CHD) sits in the Consumer Defensive sector, specifically the Household & Personal Products industry. It develops, manufactures and markets consumer household and personal care products, plus specialty products such as animal nutrition, specialty chemicals and commercial/professional cleaners. Its brand lineup includes ARM & HAMMER, OXICLEAN, BATISTE, WATERPIK, THERABREATH, HERO, TOUCHLAND, TROJAN, FIRST RESPONSE, NAIR, ORAJEL, XTRA and ZICAM. The company reports through three segments: Consumer Domestic, Consumer International and Specialty Products Division.
The financial footprint backs the idea that this portfolio has pricing power and shelf space, but not automatically a deep moat. The 12.0% net margin and 17.8% ROE show the business is both profitable and effective at turning shareholder equity into earnings, while the 0.48 beta confirms the kind of low-volatility profile typical of defensive staples. The 10-K notes the seven “power brands” accounted for roughly 70% of consolidated net sales and profits in 2025, so the competitive position is largely a function of those household names staying relevant with consumers and retailers. At the same time, Walmart represented about 23% of consolidated net sales in 2025, which is a real customer-concentration factor in a business that otherwise looks diversified by brand.
Financial posture
At a $25.0 billion market capitalization, CHD trades at a P/E of 33.8. That multiple is well above what is typical for slower-growing industrial or financial names and signals the market is pricing in reliable cash flows, brand durability and low economic sensitivity. A 33.8 P/E is not cheap by staples standards either, especially when paired with a 12.0% net margin, so a meaningful portion of today’s valuation appears to rely on continued margin resilience and steady earnings growth rather than expansion into much higher profitability.
The 17.8% ROE is a supportive figure, suggesting management is allocating capital efficiently within the existing brand portfolio. The 0.48 beta underscores why income and low-volatility investors often look at this name, but it also means equity risk/reward expectations should be framed around moderate moves rather than high-beta momentum. No debt figures are needed to see the central trade-off: investors are paying a premium multiple for a defensive, brand-led cash generator.
Strategic priorities & outlook
According to the company’s most recent 10-K filing, Church & Dwight has four clear operational priorities. First, it is repositioning the portfolio toward faster-growing value and premium lines after exiting Flawless, Spinbrush, the Waterpik showerhead business and the VMS brands. Second, it is integrating the Touchland hand-sanitizer acquisition and trying to realize its intended contribution to sales and earnings. Third, it wants to expand the seven power brands globally, viewing them as having significant international runway. Fourth, it is continuing to build supply-chain resilience, maintaining qualified dual sources for roughly 70% of direct materials spend.
These priorities matter because they explain the tension in the numbers. The push into premium and value, plus the Touchland integration, is the growth story. The exits and dual-sourcing push are the defensive risk-control story. If the power brands can grow overseas at an incremental pace, the P/E can be justified; if integration costs drag or input inflation returns, the current valuation leaves less margin for error.
Macro & geopolitical exposure
As a Household & Personal Products company, CHD inherits the macro profile of consumer staples: demand tends to be non-discretionary, but revenue and costs are still exposed to several external factors. Currency translation can move results in the Consumer International segment. Commodity-linked inputs, such as chemicals, resins, packaging and shipping, can pressure margins when raw-material or freight costs rise. Shelf-price competition and retailer dynamics matter because Walmart alone accounted for about 23% of 2025 net sales, meaning pricing negotiations or volume shifts with that customer would have an outsized impact.
Regulatory scrutiny is also a baseline risk for personal-care products, including labeling, ingredient safety and therapeutic claims on items such as oral care and at-home health products. Trade policy, including tariffs on imported goods and components, can affect both input costs and finished-goods flow into international markets. The company’s dual-sourcing goal is a direct hedge against exactly these supply-chain vulnerabilities, but it does not eliminate the broader sector exposure to inflation, trade friction and currency.
Recent developments
News flow heading into the next report has been relatively light on company-specific events but places CHD within the broader staples conversation. On 2026-10-23, Seeking Alpha published “The Dividend Aristocrats Ranked By Quality Scores (October 2026),” and on the same date Zacks ran “Church & Dwight (CHD) Reports Next Week: Wall Street Expects Earnings Growth.” These two items frame the stock as a quality/dividend story heading into an upcoming earnings release. Earlier, on 2026-10-19, Zacks published broader household-products context with “Procter & Gamble’s Innovation Push: Catalyst for Long-Term Growth?” and “NWL Sees Broad-Based Sales Recovery: What’s Behind the Shift?” Together these headlines point to a sector focused on innovation-led recovery, pricing and volume dynamics heading into the final quarter of the year.
Earnings behavior & post-earnings drift
Over the last eight reported quarters, CHD has beaten estimates in six of them, for a 75.0% beat rate, with an average earnings surprise of 5.2%. On average, the stock has moved 1.32% in the five trading days after earnings, classified as an upward drift. The directional label sounds straightforward, but the quarter-by-quarter detail is more complicated.
Looking at the last four reports, the relationship between surprise direction and price follow-through is inconsistent. On 2025-10-31, EPS came in at $0.81 versus $0.736 estimate, a 10.1% beat, yet the stock fell 1.61% the next day and 0.95% over the following week. On 2026-05-01, a 2.0% beat on $0.95 versus $0.931 triggered a 3.26% next-day drop and a 2.69% five-day decline. By contrast, the most recent quarter on 2026-07-31 was a miss — actual EPS $0.89 versus $0.896 estimate, a 0.7% negative surprise — and the stock still rose 1.21% the next day and 4.48% over five days. The only quarter in this four-report window where a beat led to a clean positive drift was 2026-01-30, when a 2.9% surprise ($0.86 versus $0.836) was followed by a 1.13% next-day move and a 4.45% five-day move.
That pattern is useful for framing risk around the next earnings date, scheduled for 2026-10-30 before the open, with the consensus EPS estimate at $0.90. The average 5.2% surprise and 75% beat rate suggest the company usually clears the bar, but the secondary market reaction depends on much more than just the headline beat. Guidance, gross-margin commentary and updates on the Touchland integration are likely bigger swing factors than the number itself.
Frequently Asked Questions
What are Church & Dwight’s main business segments and largest brands?
The company operates through Consumer Domestic, Consumer International and Specialty Products Division. Its best-known brands include ARM & HAMMER, OXICLEAN, BATISTE, WATERPIK, THERABREATH, HERO, TOUCHLAND, TROJAN, FIRST RESPONSE, NAIR, ORAJEL, XTRA and ZICAM. Seven “power brands” represented approximately 70% of consolidated net sales and profits in 2025.
How has CHD typically traded after earnings?
Over the last eight quarters CHD beat estimates six times (75%) with an average surprise of 5.2%, and the five-day post-earnings drift averaged 1.32% up. However, the reaction has not consistently followed the surprise direction: for example, the 2026-05-01 beat was followed by a 3.26% next-day drop, while the 2026-07-31 miss was followed by a 4.48% five-day gain.
Why does CHD trade at a P/E of 33.8?
The 33.8 multiple reflects investor willingness to pay a premium for CHD’s defensive cash flows, brand portfolio and 0.48 beta. Offsetting that premium are a 12.0% net margin and 17.8% ROE, which are solid but imply the stock is priced for continued stability rather than dramatic earnings acceleration.
For a deeper dive into how analysts are sizing up these factors, including price target dispersion, rating changes and model assumptions around the Touchland integration and power-brand expansion, review the full institutional verdict on the ticker page.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-07-31 | $0.89 | $0.896 | -0.7% | +1.21% | +4.48% |
| 2026-05-01 | $0.95 | $0.931 | +2% | -3.26% | -2.69% |
| 2026-01-30 | $0.86 | $0.836 | +2.9% | +1.13% | +4.45% |
| 2025-10-31 | $0.81 | $0.736 | +10.1% | -1.61% | -0.95% |
| 2025-08-01 | $0.94 | $0.857 | +9.7% | - | - |
| 2025-05-01 | $0.91 | $0.896 | +1.6% | - | - |
Previous CHD editions
Get the institutional verdict on CHD
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the CHD verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.